Jan Wehkamp
Janssen (United States)(US)
Publications by Year
Research Areas
Inflammatory Bowel Disease, Antimicrobial Peptides and Activities, Microscopic Colitis, Probiotics and Fermented Foods, Pediatric health and respiratory diseases
Most-Cited Works
- → Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial(2012)1,472 cited
- → Reduced Paneth cell α-defensins in ileal Crohn's disease(2005)963 cited
- → NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression(2004)795 cited
- → A Chromosome 8 Gene-Cluster Polymorphism with Low Human Beta-Defensin 2 Gene Copy Number Predisposes to Crohn Disease of the Colon(2006)561 cited
- → NF-κB- and AP-1-Mediated Induction of Human Beta Defensin-2 in Intestinal Epithelial Cells byEscherichia coliNissle 1917: a Novel Effect of a Probiotic Bacterium(2004)467 cited
- → Reduction of disulphide bonds unmasks potent antimicrobial activity of human β-defensin 1(2011)440 cited
- → Human α-Defensin 6 Promotes Mucosal Innate Immunity Through Self-Assembled Peptide Nanonets(2012)410 cited
- → Probiotic lactobacilli and VSL#3 induce enterocyte β-defensin 2(2008)351 cited
- → NOD2/CARD15 Mediates Induction of the Antimicrobial Peptide Human Beta-defensin-2(2005)337 cited
- → A ntimicrobial peptides and gut microbiota in homeostasis and pathology(2013)323 cited